메뉴 건너뛰기




Volumn 10, Issue SUPPL. 1, 1999, Pages

Intergroup collaboration in ovarian cancer: A giant step forward

Author keywords

Intergroup trials; International collaboration; Ovarian cancer

Indexed keywords

CANCER RESEARCH; CANCER SURVIVAL; CONFERENCE PAPER; EXPERIENCE; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; META ANALYSIS; OVARY CANCER; PATIENT CARE; PRIORITY JOURNAL;

EID: 0032955007     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0923-7534(20)31490-3     Document Type: Conference Paper
Times cited : (6)

References (10)
  • 1
    • 0025861545 scopus 로고
    • Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis
    • The Ovarian Cancer Meta-Analysis Project. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. J Clin Oncol 1991; 9: 1668-74.
    • (1991) J Clin Oncol , vol.9 , pp. 1668-1674
  • 2
    • 0026679287 scopus 로고
    • Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma
    • Fanning J, Bennet TZ, Hilgers RD. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma. Obstet Gynecol 1992; 80; 954-60.
    • (1992) Obstet Gynecol , vol.80 , pp. 954-960
    • Fanning, J.1    Bennet, T.Z.2    Hilgers, R.D.3
  • 3
    • 0028948614 scopus 로고
    • Impact of doxorubicin on survival in advanced ovarian cancer
    • A'Hern RP, Gore ME. Impact of doxorubicin on survival in advanced ovarian cancer. J Clin Oncol 1995; 13: 726-32.
    • (1995) J Clin Oncol , vol.13 , pp. 726-732
    • A'Hern, R.P.1    Gore, M.E.2
  • 4
    • 0030843953 scopus 로고    scopus 로고
    • Meta-analyses of chemotherapy regimens for ovarian carcinoma : A reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide
    • West RJ, Zweig SF. Meta-analyses of chemotherapy regimens for ovarian carcinoma : a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide. Eur J Gynaec Oncol 1997; 18: 343-8.
    • (1997) Eur J Gynaec Oncol , vol.18 , pp. 343-348
    • West, R.J.1    Zweig, S.F.2
  • 5
    • 0026055728 scopus 로고
    • Chemotherapy in advanced ovarian cancer : An overview of randomized clinical trials
    • Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer : An overview of randomized clinical trials. Br Med J 1991; 303: 884-93.
    • (1991) Br Med J , vol.303 , pp. 884-893
  • 6
    • 0027724022 scopus 로고
    • What have we learnt from metaanalyses in ovarian cancer ?
    • Kaye SB, Van Houwelingen HC. What have we learnt from metaanalyses in ovarian cancer ? Ann Oncol 1993; 4 (Suppl 4): S79-S82.
    • (1993) Ann Oncol , vol.4 , Issue.4 SUPPL.
    • Kaye, S.B.1    Van Houwelingen, H.C.2
  • 7
    • 0000433785 scopus 로고
    • A phase III trial comparing cisplatin/cytoxan (PC) and cisplatin/Taxol (PT) in advanced ovarian cancer (AOC)
    • Abstr 808
    • McGuire WP, Hoskins WJ, Brady MF et al. for the Gynaecologic Oncology Group (GOG). A phase III trial comparing cisplatin/cytoxan (PC) and cisplatin/Taxol (PT) in advanced ovarian cancer (AOC). Proc ASCO 1993; 12: 255 (Abstr 808).
    • (1993) Proc ASCO , vol.12 , pp. 255
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3
  • 8
    • 0000264166 scopus 로고    scopus 로고
    • Updated analysis shows a highly significant improved overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer : Mature results of the EORTC-GCCG, NOCOVA, NCIC CTG and Scottish Intergroup Trial
    • Abstr 1394
    • Stuart G, Bertelsen K, Mangioni C et al. Updated analysis shows a highly significant improved overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer : mature results of the EORTC-GCCG, NOCOVA, NCIC CTG and Scottish Intergroup Trial. Proc ASCO 1998; volume 17: 361a (Abstr 1394).
    • (1998) Proc ASCO , vol.17
    • Stuart, G.1    Bertelsen, K.2    Mangioni, C.3
  • 9
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire WP, Hoskins WJ, Brady ME et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
    • (1996) N Engl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.